Richard A. Lerner is Director at Intra-Cellular Therapies, Inc. (ITCI). They have made 7 open-market trades across 2 companies since 2012, most recently 2021-09-30.
CIK 0001316274
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $612K since 2012, against 2 sales. Across 5 scored buys the stock is up 0.6% at ninety days, and 0.2 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 20% | 80% | 80% |
| Avg Move | -12.5% | +0.6% | +0.6% |
| Alpha | -7.8% | +0.6% | +0.2% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ITCI | SELL | 2020-05-11 | 2020-05-13 | $20.50 | $72K | +12.8% | +3.3% | -2.9% |
| ITCI | SELL | 2017-12-11 | 2017-12-13 | $15.09 | $106K | +3.1% | +24.9% | +59.6% |
| OPK | BUY | 2017-06-05 | 2017-06-06 | $6.31 | $63K | +3.0% | -0.5% | -0.3% |
| OPK | BUY | 2015-06-05 | 2015-06-09 | $15.90 | $199K | -16.4% | +0.8% | +0.8% |
| OPK | BUY | 2013-03-15 | 2013-03-19 | $7.63 | $100K | -16.4% | +0.8% | +0.8% |
| OPK | BUY | 2012-05-17 | 2012-05-18 | $4.50 | $20K | -16.4% | +0.8% | +0.8% |
| OPK | BUY | 2012-05-16 | 2012-05-17 | $4.60 | $230K | -16.4% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.